Home › Funds › BAKER BROS. ADVISORS LP › IONS

BAKER BROS. ADVISORS LP position in IONS

IONIS PHARMACEUTICALS INC · Health Care

BAKER BROS. ADVISORS LP reported holding 2,047,727 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$162.4M, representing 0.85% of its reported portfolio and ranking #20 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed IONS holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)2.05M sh
Reported value held$162.36M
Portfolio Weight0.85%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's IONS position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in IONS in Q3 2024 at 223,470 shares (US$9.0M). The position peaked in Q2 2026 at 2,047,727 shares, worth US$162.4M. Across 7 filings, BAKER BROS. ADVISORS LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,047,727 shares valued at US$162.4M. Notable position changes include a 60% increase in Q4 2024 (shares fell 14% over the following quarter), a 216% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 223.47K $8.95M New
Q4 2024 357.92K $12.51M Add
Q1 2025 357.92K $10.80M Hold
Q3 2025 566.80K $37.08M New
Q4 2025 1.79M $141.75M Add
Q1 2026 2.05M $153.76M Add
Q2 2026 2.05M $162.36M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held IONS?

BAKER BROS. ADVISORS LP has disclosed IONS holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

What is BAKER BROS. ADVISORS LP's current position in IONS?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 2.05M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $162.36M, representing 0.85% of its reported portfolio and ranking #20.

Has BAKER BROS. ADVISORS LP been buying or selling IONS?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in IONS. The position peaked in Q2 2026 at 2.05M shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.